OACCW
OACCW
Oaktree Acquisition Corp. III Life Sciences • NASDAQ
$0.76 ▼ -16.49% (-0.15)
Market Cap $18.70 M
52w High $0.99
52w Low $0.75
Dividend Yield 0%
P/E 0
Volume 2.64K
Outstanding Shares 24.61M
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $225.579K ▼ | $1.967M ▲ | 0% | $0.08 | $0 ▲ |
| Q2-2025 | $0 | $269.81K ▲ | $1.874M ▲ | 0% | $0.08 ▲ | $-269.81K ▼ |
| Q1-2025 | $0 | $0 | $1.296M | 0% | $0.068 | $0 |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.329M ▼ | $201.25M ▲ | $8.246M ▲ | $-6.765M ▼ |
| Q2-2025 | $1.385M ▲ | $199.176M ▲ | $8.138M ▲ | $191.038M ▲ |
| Q1-2025 | $1.281M | $197.241M | $8.077M | $-6.519M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.967M ▼ | $-56.518K ▲ | $191.99M ▲ | $-193.437M ▼ | $-56.518K ▼ | $-56.515K ▲ |
| Q2-2025 | $2.153M | $-131.998K | $250K | $0 | $28.315K | $-131.998K |
Market Cap $18.70 M
52w High $0.99
52w Low $0.75
Dividend Yield 0%
P/E 0
Volume 2.64K
Outstanding Shares 24.61M
About Oaktree Acquisition Corp. III Life Sciences
https://www.oaktreeacquisitioncorp.com/o...Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $225.579K ▼ | $1.967M ▲ | 0% | $0.08 | $0 ▲ |
| Q2-2025 | $0 | $269.81K ▲ | $1.874M ▲ | 0% | $0.08 ▲ | $-269.81K ▼ |
| Q1-2025 | $0 | $0 | $1.296M | 0% | $0.068 | $0 |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.329M ▼ | $201.25M ▲ | $8.246M ▲ | $-6.765M ▼ |
| Q2-2025 | $1.385M ▲ | $199.176M ▲ | $8.138M ▲ | $191.038M ▲ |
| Q1-2025 | $1.281M | $197.241M | $8.077M | $-6.519M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.967M ▼ | $-56.518K ▲ | $191.99M ▲ | $-193.437M ▼ | $-56.518K ▼ | $-56.515K ▲ |
| Q2-2025 | $2.153M | $-131.998K | $250K | $0 | $28.315K | $-131.998K |
CEO
Zaid Pardesi
Compensation Summary
(Year 2024)
Salary $0
Bonus $0
Stock Awards $0
Option Awards $0
Incentive Plan Pay $0
All Other Compensation $0
Outstanding Value $0
Total Compensation (Unknown At The Moment)
CEO
Zaid Pardesi
Compensation Summary
(Year 2024)
Salary $0
Bonus $0
Stock Awards $0
Option Awards $0
Incentive Plan Pay $0
All Other Compensation $0
Outstanding Value $0
Total Compensation (Unknown At The Moment)
Industry Shell Companies
Sector Financial Services
Went public October 6, 2025
Method of going public SPAC
Full time employees 0
Ratings Snapshot
Rating : C+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 5
Debt To Equity 1
Price To Earnings 4
Price To Book 1
Overall Score 2